Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke

被引：8
作者：
Kimura, Genjiro [1 ]
机构：
[1] Japan Org Occupat Hlth & Safety, Asahi Rosai Hosp, Hirako Cho North 61, Owariasahi 4888585, Japan
来源：
CIRCULATION JOURNAL | 2017年 / 81卷 / 06期
关键词：
CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN; DISEASE;
D O I：
10.1253/circj.CJ-17-0040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：898 / 898
页数：1
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?
    Ujjawal, Aditi
    Schreiber, Brittany
    Verma, Ashish
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [42] Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis
    Aldafas, Rami
    Crabtree, Tomas
    Alkharaiji, Mohammed
    Vinogradova, Yana
    Idris, Iskandar
    AGE AND AGEING, 2024, 53 (01)
  • [43] CARDIOPROTECTIVE MECHANISMS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS
    Mkrtumyan, Ashot M.
    Markova, Tatyana N.
    Mishchenko, Nadezhda K.
    DIABETES MELLITUS, 2021, 24 (03): : 291 - 299
  • [44] Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes
    Steinberg, Helmut O.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 398 - 408
  • [45] Sodium-glucose cotransporter 2 inhibitors and renal function
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2015, 7 (03) : 295 - 298
  • [46] Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects
    Satirapoj, Bancha
    KIDNEY DISEASES, 2017, 3 (01) : 24 - 32
  • [47] Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
    Salah, Husam M.
    Verma, Subodh
    Santos-Gallego, Carlos G.
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Khan, Muhammad Shahzeb
    Lopes, Renato D.
    Al'Aref, Subhi J.
    McGuire, Darren K.
    Fudim, Marat
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (05) : 944 - 956
  • [48] Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
    Kuchay, Mohammad Shafi
    Farooqui, Khalid Jamal
    Mishra, Sunil Kumar
    Mithal, Ambrish
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 213 - 230
  • [49] Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
    Filippatos, T. D.
    Tsimihodimos, V.
    Elisaf, M. S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1581 - 1583
  • [50] Pharmacoeconomic evaluation of sodium-glucose transporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes
    Rahman, Wedad
    Solinsky, Paul Joseph
    Munir, Kashif M.
    Lamos, Elizabeth M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 151 - 161
12345